Search details
1.
A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer.
Future Oncol
; 2024 Apr 29.
Article
in English
| MEDLINE | ID: mdl-38682560
2.
Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile.
Prostate
; 83(9): 840-849, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36988342
3.
Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial.
Oncologist
; 28(4): 333-340, 2023 04 06.
Article
in English
| MEDLINE | ID: mdl-36576173
4.
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.
Lancet Oncol
; 22(7): 919-930, 2021 07.
Article
in English
| MEDLINE | ID: mdl-34051177
5.
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV201): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 22(6): 872-882, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33991512
6.
PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer.
Future Oncol
; 17(2): 137-149, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32938232
7.
Characterization of Clinical Cases of Malignant PEComa via Comprehensive Genomic Profiling of DNA and RNA.
Oncology
; 98(12): 905-912, 2020.
Article
in English
| MEDLINE | ID: mdl-32966992
8.
Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer.
Oncologist
; 24(5): 688-690, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30728277
9.
BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma.
J Transl Med
; 17(1): 386, 2019 11 25.
Article
in English
| MEDLINE | ID: mdl-31767020
10.
Current Status and Future Direction of Immunotherapy in Urothelial Carcinoma.
Curr Oncol Rep
; 21(3): 24, 2019 02 26.
Article
in English
| MEDLINE | ID: mdl-30806823
11.
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.
Lancet
; 389(10064): 67-76, 2017 01 07.
Article
in English
| MEDLINE | ID: mdl-27939400
12.
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 18(11): 1483-1492, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28967485
13.
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.
Lancet
; 387(10031): 1909-20, 2016 May 07.
Article
in English
| MEDLINE | ID: mdl-26952546
14.
Pembrolizumab monotherapy for high-risk, non-muscle invasive bladder cancer - Authors' reply.
Lancet Oncol
; 22(9): e380, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34478664
15.
Cytotoxic and DNA-targeted therapy in urothelial cancer: have we squeezed the lemon enough?
Cancer
; 121(2): 179-87, 2015 Jan 15.
Article
in English
| MEDLINE | ID: mdl-25091501
16.
Whole-lesion diffusion metrics for assessment of bladder cancer aggressiveness.
Abdom Imaging
; 40(2): 327-32, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25106502
17.
The impact of taxanes on the management of genitourinary cancers.
Anticancer Drugs
; 25(5): 555-60, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24525590
18.
Recent Clinical Trials Explore Immunotherapies for Urothelial Carcinoma.
Oncology (Williston Park)
; 33(4): 132-6, 2019 Apr 15.
Article
in English
| MEDLINE | ID: mdl-30990565
19.
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC).
Prostate Cancer Prostatic Dis
; 2024 Feb 10.
Article
in English
| MEDLINE | ID: mdl-38341461
20.
Phase II study of everolimus in metastatic urothelial cancer.
BJU Int
; 112(4): 462-70, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23551593